Healthcare News 15

• "Exciting Results Expected from Nasal Decongestant( Otrivin) in a Spray Form"
• 18 months too late for this outbreak, but may be the way toward the future.
• 2 generic drugs - Imitrex and Eloxatin
• 3D imaging is critical for accurate diagnosis and treatment planning in orthodontics
• 4SC Phase II trial of the HDAC inhibitor 4SC-201
• A Difficult Pathogen Meets its Match
• A direct way against allergy!
• A drop in the price of OTC allergy eye drops?
• A GREAT STEP FORWARD IN RX OF C.DIFFICILE
• A Kit For Research Use
• A Low Cost EMR System From Wal-Mart?
• A missed opportunity - or is it?
• A Novel Option for Management of Malignant Ascites.
• A September to Watch-- and Remember: H1N1 Vaccine 1st Tipping Point Positive
• A Trillion Here...A Trillion There...Pretty Soon You're Talking Real Money!
• A useful advance
• Abbott to become a comprehensive structural heart disease provider
• Abbott's Q2 Molecular Diagnostics Sales Increase 21%
• According to Datamonitor, Sales in 2017 will be $3B versus $1B, with Reduced Costs
• Advantage of topical treatment vs intra-vitreal injections
• Advantage to Victory product
• Agendia Opens CLIA Genomics Lab
• Alcon ReStor +3 offers excellent near, intermediate, and distance vision
• Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
• Alcon's Potential New Glaucoma Treatment: Anecortave Acetate.
• AMA endorsement
• AMO Grows Portfolio, Potential with Acquisition of Accommodating Lens Implant
• An $80 Billion Giveback to the Government by Pharma can Result in a 2 times ROI !!!
• An important landmark for Nycomed's Daxas
• Analysis of virtually all Obama healthcare initiatives, experiments and methodologies incl Green Bay
• Analyst upgrades of Genomic Health: Lagging or leading indicator
• ANATOMICAL PATHOLOGY BUSINESS ANALYSIS
• And...The Race is on to Get Comprehensive National Healthcare Reform Legislation Passed
• Animal health offers growth avenue for big pharma players in these tough times!!!!
• Another chink in the branded PPI armor
• Another good result for Roche.
• Another melanoma drug fails in a late stage trial
• Another option in NSCLC...?!?
• Antioxidant effect
• Antiplatelet drugs in a horse race
• Appropriate use of iPhone technology yields maximum benefits
• Are Ambulatory Surgery Centers (ASCs) double dipping with the "Company Model"?
• Are Health Courts the Last Best Chance for Bipartisan Reform?
• Are the New Molecular Assays for CDAD Worth the Cost?
• AstraZeneca's (AZN) Cholesterol Lowering Drug Crestor Reduces Risk of Developing Venous Thromoembolism (VTE)
• Atritech's Watchman Atrial appendage closure device could be a useful alternative to warfarin in patients with Atrial Fibrillation.
• Aurobindo continues to strenghten its presence in US Markets!!
• Aurobindo Pharma's Escitalopram will be a big mover ... when it comes out in 2011
• Balancing the Problem and the Panic Around Swine Flu
• Bausch & Lomb's FDA Approved Topical Eye Antibiotic Besivance (Besifloxacin) Will Become Game Changer
• Bayer and Algeta Enter Global Agreement
• benefit of Iressa
• Better late than never for Novo's new diabetes drug
• Better Tuberculosis vaccine is desperately needed, but will a vaccinia-based vaccine be safe and embraced?
• Big impact on a big market!
• Bio Fuel, planet and economy saving
• Biocon & the Indian Biotech story!!!
• Biotech companies can recover if the fundamentals are there
• Biotech the big driver?
• Biotech will Provide the Next Big Breakthroughs
• Biotechnology can be the next big driver for the pharma sector
• Bivaracetam and Keppra
• Blinatumomab for Leukemia & Lymphoma; MedImmune Hands it Back to Micromet
• both companies will benefit from this deal
• Breast Cancer Diagnostic Test
• Breast Cancer Education Bill
• But Astellas is an acquisition target as well
• Can DNA testing replace routine PAP smears
• Can we trust Sinovac swine flu results?
• Cancer Rates Expected to Post Sharp Increase
• Capitation All Over Again
• Caraco's FDA Tangle
• Cardiovascular events
• Care rationing under the guise of quality control
• Catract Surgery and Premium IOLs
• Caution against genetic testing
• Cautious optimism appropriate for a cancer with a historically dismal outlook.
• CDC Issues Genetic Testing Recommendations
• Cephalon’s Nuvigil, A Treatment for Jet Lag and Bipolar Depression?
• Cephalon's Nuvigil
• Cepheid Receives Canadian Approval for MRSA/SA Tests
• Certriad: Wonderful drug. Terrible name
• Changing Pharma business trends in India
• Cheap HPV testing is great news for poor countries
• Cladribine results
• CLIA Lab Gets Certifiication
• Clostridium difficile PCR-based test may gain quick adoption
• Colorectal Cancer Company
• Comments on the Viropharma Response to FDA Guideline on Generic Vancocin
• Comparative Effectiveness Research Panel Hits the Ground Running
• Competitive Dynamics in Contact Lenses
• Congressional Passage of the President's Budget Bodes Well for Large Scale Healthcare Reform this Year
• Converting to an EHR in a rural hospital network is hard but worth it.
• cosmetology growing in India
• Cost Effective Healthcare
• Cost will be the tricky point...
• Costly diabetes drugs are better than generics
• Could Health Insurers be Part of the Cost Containment Solution After All?
• Dainippon Sumitomo acquires a bridgehead and settles Sepracor's uncertain future
• Darusentan and Resistant Hypertension
• Decidedly Fiction
• Defining Meaningful Use Meaningfully
• Denosumab May Help to Salvage Bone Health in Metastatic Disease
• Dibigatran will change how we manage atrial fibrillation
• Direct to Consumer Genetic Testing Reviewed by SACGHS
• Do Patients Finally have an Alternative to Anticoagulation for Afib?
• Does Genius-STEMI Trial Spell Trouble for Orbus-Neich Genous Stent?
• Does Healthcare really need more money??
• Dr. Eggermont discusses his approach to adjuvant therapy for high risk melanoma
• Dr. Richard Frank Lavi, MD
• Dronedarone will change medical management of atrial fibrillation
• Drug use in animals is important to human health.
• Efalizumab Withdrawn Due to Serious Side Effect
• Electronic Medical Records Sold through Walmart
• Electronic patients records
• Emerging role of Dronedarone in management of Atrial Fibrillation
• EMR Debate
• EMR Stimulus - Much to do about something, but less than meets the eye
• EMR systems and Mass Marketing
• EMR: burden for clinicians.
• EMRs are the future but medicine remains mired in the past
• Enigma Diagnostics European Patent Issued
• Enrollment in Poniard's Phase III Study of Picoplatin is Complete
• Epo in Myeloma: A good Idea. Will the Data Bear it Out?
• European Commision Re-Approves Neupro For Parkinson's Disease and RLS
• Evaluation of Influenza Vaccines
• Evolving centrality of biotech for pharma
• EXACT Sciences Expands Technology Portfolio
• EXACT Sciences Receives Warning
• eye drop corticosteroids (topical steroids) for LASIK and cataract surgery and dry eye
• Failure is not an option
• Fampridine SR / A novel approach to MS
• Fampridine-SR -- anxiously awaited new MS therapeutic
• FDA and CMS Discuss DTC Genetic Testing
• FDA and EMEA inspections
• FDA Approval for HPV tests provides huge opportunity for Hologic
• FDA Gives Takeda Complete Response on Alogliptin plus Actos Combination Therapy
• FDA Regulatory Tiger Gets Teeth
• FDA Sends Warning Letters to Three Diagnostic Firms
• Federal Council for Comparative Effectiveness Research Goes to Work
• Final Piece of the Jigsaw for Takeda and Pioglitazone
• Finally an alternative to Warfarin for patients with Atrial Fibrillation
• Finally some Good News from Ranbaxy !!!
• First swine flu vaccine in the world goes into human trials
• Flu Vaccine the emerging cash cows for Pharma, USD 10 Billion oppurtunity!!!
• Fortis begins its road show for upcoming $ 250 million rights issue
• Fortis is all set to become the medical titan in India
• Fortis is Catching Up!
• Four studies published in The Lancet show roflumilast
• From the People who Brought You $4 Prescriptions: Discount Electronic Medical Records!
• Fullerine/NMDA antagonist action
• Gardasil for boys? If you're not kidding, at least make it about science this time.
• GDH-PQQ Enzyme Used in Blood Glucose Monitoring Strips May Lead to Fatal Errors
• GE Brings Good Things to Life (and Health)
• Genentech and Dako Collaborate To Increase Herceptin Use In Gastric Cancer
• Generic Business Development activity!!!
• Generic Losartan Will Probably Not Make Huge Impact in Malaysia
• Generics seek brands, Big pharma seek generics!
• Genomic Health Stock Upgraded
• Genous bio-engineered (endothelial cell capture) stent results presented at the American College of Cardiology Annual Meeting
• Gilead beats Astellas in bid for CV Therapeutics - the race for consolidation?
• Glaxo Stiefel deals with the dermatology question
• Glaxo, Daiichi Sankyo, Pfizer & Watson are embracing generic manufactures & manufacturing?
• Gleevec shows promise as targeted melanoma treatment
• Glenamrk a good buy during down slides!!!
• Glenmark Has pulled an ACE here
• Glenmark Story Keeps getting better day by day!!!
• Glenmark the Hidden Jewel of Indian Pharma
• Glenmark the Hidden Jewel of Indian Pharma !!!
• Global Pharma Business set for a complete Make Over!!!!
• Going to a fully functional electronic medical record - is the task overwhelming?
• Good and Bad From Astellas Joint Venture With Maxygen
• Good for PR, but how valid?
• Good idea in a large company
• Good In Theory, But Not In Practice
• Good medical care as good as angioplasty for stable coronary artery disease
• Good Model!
• Good move, keeping pace with the market demand.reta
• Good News for Vivus on Qnexa
• Google Invests $2.6MM in 23andMe
• Great Basin Scientific Completes Financing Round and Plans MRSA Test
• Great drug fot the wrong economic time
• Green Bay's Healthcare may Soon Rival the Packers in Notoriety
• GSK - Reddy's will it be a reality???
• GSK & Dr Reddy's: Generic Products, Not Generic Thinking
• GSK Boost an indication of Merck's Deeper Problem?
• GSK plans to introduce Relenza in the Indian market
• GSK Reaffirms trusts in Indian Pharma Story!!!
• HandyLab Files Lawsuit
• Have You Looked at Clouds from Both Sides Now?
• Health care forum emphasizes prevention, health IT, comparative effectiveness, quality initiatives
• Healthcare BPO players set for Booster Dose!!!
• Healthcare industry to double in value by 2012: KPMG India Report
• Healthcare Reform 2.0: The Stars Seem to be in Better Alignment this Time
• Healthcare reform...a disater waiting to happen!
• Healthcare reforms.
• Healthyimagination: moving towards multidisciplinary, cost effective health delivery
• Helicos Biosciences Evaluates Strategic Alternatives
• Herceptin for Gastric Cancer? Roche Says, "Yes!"
• High growth from Accerl8
• Hologic REceives FDA Approval for HPV Tests
• Hopes in Swine Flu Vaccine
• Hospitals Must Remove their Revolving Doors to Fare Well in a Reformed Health System
• Hospitals Must Upgrade Their Data Centers for Electronic Medical Record Surge
• How Accountable Care Organizations may Provide the Bridge to a Bipartisan Bill
• How do we respond to the new influenza threat?
• How much store to put on Sinovac press release?
• How Physicians Can Lead Healthcare Reform (and Help Save the World in the Process)
• How the Government's Spending Spree on Electronic Medical Records will Reshape the Industry
• HPV vaccine for males
• If we had learned to spell HIPAA correctly, this wouldn't be a surprise.
• Illumina Launches Personal Genome Service
• Illumina Offers New Personalized Gene Sequencing Service
• Implications for Influenza Antivirals and Vaccines
• Importance of the rapid C.Difficile DNA test
• Importing health care: trials and tribulations
• Inconclusive Data
• Increasing access to treatments for hepatitis C: oral interferon
• Indian Pharma to set to hit $ 70 Bn Jackpot
• Indian Pharma's Branded play!!!
• Indian set to become the HUB of Clinical Research
• India's pharma exports to US tumble 37%; A result of overall downward trend in the Economy!!!
• Innovation in Pharmaceutical Product Marketing
• Innovation or a quid pro quo?
• Institute of Medicine Posts its "Top 100" List of Comparative Effectiveness Research Priorities
• Iressa: will it be a new therapeutic option or will it replace another existing option?
• Is Aurobindo trying to do a Satyam on its investors!!!
• Is It Time To Replace The 'Pap' Test With HPV Viral Testing?
• Is this the end of Bifeprunoxyndrome.
• Is U.S. Medical Device Development In Trouble ?
• Its Raining JV's in Indian Biotech Sector - Novavax - Cadila done !!!
• Japan's patent prowess
• Jet Lag a Forme Fruste of Shift Work Insomnia
• Johnson & Johnson to Tap into huge Alzheimer's Market
• Joint Research Projects on TB can open up new era in Management of MDR/XDR-TB
• Jumping off the Bandwagon: Decline in Sequenom shares takes world by surprise
• Knome and SeqWright Team Up to Offer Genetic Services
• Lab Corp seeks to Diversify
• LabCorp Acquisiton
• Large study supports sceptics, but unlikely to slow down HPV DNA test market
• Laser Vision Correction for Presbyopia is here!
• LDL chlosterol and CRP
• Life Science Companies Achieve Spectacular Growth
• Life Science Companies Report Weak Sales and Earnings
• Lipocalin2 (LCN2): Another Potential Marker of Breast Cancer Spread
• Lupin FDA woes far from over !!!
• Lurasidone will be an important new option for the treatment of Schizophrenia
• MADIT CRT Will Increase Use of CRT Defibrillators
• MADIT-CRT trial - How will it impact the ICD/CRT market
• Making of a World leader !!!!
• Making the Best of Heath Care Reform Will Require Increased Efficiency
• Malpractice reform-key issue to reduce cost
• Marketing Breakfast Cereals in a Down Economy
• Mass. Proposed Payment System Strikes Fatal Blow Against Private Practice
• MDS Revenue Declines 21% in Q2
• Medicare cuts will make specialty healthcare difficult for seniors to receive
• Medicare System Overhaul Proposed by Two Senators Is Unworkable
• Meta-analysis of probiotics in atopic dermatitis
• Molecure for rare diseases?
• Money and Meaningful Use
• More to do...
• More Uses than Diagnosis
• Mortality risk low 15 years after radical prostatectomy
• much retoric no answers
• Multi Bullion $$$ Industry !!!! The next Sector to watch
• Multiple Sclerosis: Told him to get up and walk and the man did so!Patients with multiple sclerosis may benefit from taking a bird poison? Potassium channel blockers in multiple sclerosis
• Multivitamin Supplements can not prevent Cancer or Heart Disease.
• Multivitamins, filtered water, shark cartilage, black magic etc.
• My experience as a Primary Care provider
• Myriad Genetics Sees Lower Sales for 4Q and 2009
• Myriad Genetics Sets Record and Distribution Dates
• Naproxen and Alzheimer'Alzheimer's/s
• Natco The Rising Star !!!!
• Negligent Patient Care: The Impact on the Cost of Health Care
• neupro is good for parkinson disease and restless legs syndrome
• Neupro Makes a Return
• New and Generic Biotechnology Drug Growth.
• New Clinical Diagnostic Products at AACC
• New Developments in Ocular Inflammation
• New Direction for an Ongoing Problem
• New Drug targets for Alzheimers neurodegeneration?
• New entrant to DTC genetic testing market raises regulatory and financial questions
• New generic oxycodone prvider
• new long acting formulation of an old dependable drug
• New Medicare Proposals promote Promote the BiG Business of Medicine
• New PCR test--statistical improvement, but clinical question mark
• New perspectives in vascular access for hemodialysis: Autologous grafts
• New Rapid Test for C. Difficile
• New treatment of Gout
• New Treatment Option for the Hearing Impaired
• New Vaccine offers Hope
• Nexavar and Xeloda - Yet Another Breast Cancer Combination Shows Benefit
• NIH to Fund Three New Programs
• No Bidding War For CV Therapeutics From Astellas
• No need to lag as the day goes on for sleep apnea, narcolepsy and jet laggers
• No real support for government healthcare
• No weight gain or even weight loss with new diabetes drugs
• Not a unique product except perhaps in India
• Not what it's being portrayed as and not all that effective
• Novagali Phase II Results are Cyclokat (R) for Dry Eye Promising
• Novartis Targets Global Renin Angiotensin System Inhibition
• Nuvigil for Jet lag
• NUVIGIL for Jet Lag -- An Important Broad New Indication for Cephalon
• Nuvigil: reduced sleepiness in people with jet lag traveling East from the USA to France.
• NY State Regulates DTC Genetic Testing Labs
• Nycomed’s Daxas takes an important step forward
• Old-fashioned influenza vaccine manufacturing just doesnt cut it in pandemic
• Omalizumab possibly associated with cardiovascular side effects
• One $ 20 Billion Pill for all of Wockhardt's problems!!!
• One-year results of FREE-study support the use of kyphoplasty in osteoporotic vertebral compression fractures (Kyphon, Medtronic)
• Onglyza on the verge
• Oramed Pharmaceuticals Begins Clinical Trials on Oral GLP-1 Analog, ORMD 0901
• Orthopedic Perspective on GLPG0259
• Other Issues to Consider With Reclast
• Othera's Eye Drop to Cure ARMD Seems Promising But Too Early to Tell
• Ozurdex Opens Doors for All Retinal Treatment, Not Just Retinal Vein Occlusions
• Pacific Biosciences Prepares to Enter the Nex-Gen Sequencing Field
• Panacea the Next Big Biotech player
• Pandemic Influenza Vaccine for 2009: More to Consider
• PARP Inhibitor shows very encouraging results in metastatic breast cancer
• Patenting Microorganisms is Unethical and Will Halt Knowledge.
• Pathway Genomics Offers DTC Genetic Testing
• PathXchange Signs Up a Record 1,000 Pathologists in 2 Months
• Pay for performance Medicare "reform"
• PE..its about time
• Pentavalent vaccinations are great if you can purchase them
• Peplin could be beneficial.
• Peramivir's Influenza Trial Results Promising, but Report Lacks Clarity
• Pfizer Supports the Development of Stem Cell Therapies for Macular Degeneration
• Phadia Point of Care Test Approved
• Pharma Business set for major government intervention
• Pharma emphasis on emerging markets justified but more needs to be done to operate successfully
• Pharma industry is worth Rs 78,000 crore (USD 15 Billion ): 15 - 150 Billion $$$ coming up !!!
• PHOSPHAGENICS TO COMMENCE PHASE 2/3 TOPICAL DICLOFENAC TRIAL
• Physician Independence in Health Care Reform
• Physician Owned Hospitals Must Compete on Level Playing Field
• Physicians paid on Salary basis provide better quality of Health care services
• Piramal becomes 1st Pvt Sector company to Process Opium!!
• PLX-4032, the new great hope for targeted therapy in melanoma
• Positioning for the New Age of Health Information Technology
• Positive and Highly Significant Phase III Results
• Possible reasons for the withdrawal of the Shire application in Europe
• Potential game changer for patients and hospitals regarding C. difficile colitis
• Potential markets for new Roche MRSA test
• Pre - Clinical research begining to reach Indian Shores !!!
• Prescription Brand Bullys vs Generic Go-Getters
• President Obama Creates Health Reform Office
• Price Drop for Genetic Testing
• Price Drop for Genetic Testing
• Private Hospital Chains - the next Healthcare Growth Engines
• Probiotics and Atopic Dermatitis
• probiotics cure many ills
• Proficiency Standards could adversely affect case submissions for Invisalign
• Programs to predict mosquito activity important to veterinary medine and one-health.
• Promising Eye Drop for Dry Age-Related Macular Degeneration.
• Promising Idea
• Promising Results
• Promotion by Sequenom of the company's
• Proposed Medicare Changes:Too Frightening to Contemplate
• Proteome Sciences Reports Sharp Rise in 2008 Revenues
• Qforma: Finding a Scud Missle is Easier than Finding a Good Doctor
• Qforma's Online Database: Exposing Pharma's Physician Marketers?
• Qiagen Announces New Technology
• Qiagen Launches New Kit for Use in Prenatal and Cancer Detection
• Quest Diagnostics Introduces Swine Flu Test
• Ranbaxy getting out of the bush!!!
• Ranbaxy on the Rebound
• Ranbaxy Taking baby steps to recovery!!!
• Rapid DNA Clostridium difficile test useful for public health laboratories.
• Recession eating the Health Care of Globe
• Reconcilation: A Roadway to Mangled Healthcare Reform Legislation
• Relenza Opens up New era in treatment in India
• Remeron is a Great Choice
• Remote Monitoring of Cardiac Rhythm Devices Improves
• Requirement for Extra Data for Alogliptin: FDA Incompetence will Hurt Takeda and Diabetics
• Researchers Identify Gene That May Identify Patients At Risk For Metastases
• Responsive vs unresponsive depressive patients have similar electrode sites
• Rho Kinase Inibitors could be a New Approach in Glaucoma Management.
• Rituximab Approved for CLL in Europe
• RNA Inhibitor Development: A Matter of Pipeline Strategy and Technology Risk
• Roche adds to anti-MRSA arsenal in Europe
• Roche's Avastin FDA Approved for Metastatic Kidney Cancer
• Roche's real-time PCR for MRSA needs clinical tests
• Role of CROs in Pharma industry
• Rosetta Genomics' CLIA Lab Certified in 48 States
• RPG Gearing up for Biosimilars Battle post Patent expiry!!!
• Rush to production
• Safety profile similar to placebo! Can't do better than that.
• Sanofi makes a smart move
• SEC Investigates Sequenom
• Sequenom Contracts with PDI to promote SEQureDx
• Sequenom Discloses Dismissal of Patent Infringement Suit
• Sequenom may be done....
• Sequenom Shares Fall
• Sequenom's delay
• Sex - we can chemically get it up and now last longer?
• Shifting the burden of risk
• Shooting Flleas with Elephant Guns
• Sigma-Aldrich Acquires Latin Distributor Sigal
• Skepticism and The RDA
• slow down and do it right
• Small Players Will the Pharma Band Wagon
• Solvay Pharmaceuticals – prospects for a sale
• Solvay Strategy - the company appends a note
• Spreads like the Flu....
• State Medicaid Cuts May Limit Market for New Antipsychotic Lurasidone
• Stem cells for transplantation from own body fat in Multiple Sclerosis. Case reported
• Stimulus, Health Reform and Understanding the Bureaucracy of Spending
• Strengthening Senior Management always benefits an Organization
• Strides the Banglore Tiger !!!!
• SUN PHARMA GETS US NOD FOR 2 GENERIC Drugs
• Sun Pharma Makes Inroads into US Oncology Market
• Sun Pharma's ANDA March continues!!!
• Synta Melanoma study stopped due to unspecified safety concerns
• Tactic to increase speed of offers to India Pharma companies
• Takeda feels the cardiovascular pinch
• Talecris Likely Target for New Entrant into Plasma Therapeutics
• Tanning beds cause cancer
• TB Vaccines in RSA
• Technical analysis of multifocal lens implants (IOLs) and astigmatism lens implants (Toric IOLs)
• Tecnis Multifocal FDA Data Shatters the Bifocal Glasses Ceiling
• Temozolomide and Thalidomide combination therapy for melanoma cointues to show marginable efficacy with significant thromboembolic risk
• Tentative Value
• The ability for software systems to integrate and the interoperability across medical/dental imaging systems is key to cost efficiences.
• The American Medical Association Endorses "Socialized Medicine"
• The Days of Old or Maybe Not
• The Evidence Is Slim that Electronic Patient Records Will Save Money or Improve Qaulity
• The Health IT Industry's New Holy Grail: 'Meaningful Use' of their Products
• The Health Stimulus Bill...found money or pig in a poke?
• The Impact of Potential Health Care Reform on Health Plans
• THE IMPORTANCE OF PROPER DOSING AND ROUTE OF ADMINISTRATION
• The Indian Generic sucess - Facing takeover threat - how it can be convereted into Win Win for all!!!
• The introduction of the first FDA-approved mobile bearing total ankle replacement system may lead to it becoming the industry standard.
• The new love affair in Pharma Sector
• The Next Big Money spinner in Indian Biotech Space
• The Statin Revolution
• The Tables May be Turned on Healthcare Reform Opponents
• The Validity of Kyphoplasty
• The vitamin industry: easy pickings for the new adminsitration
• The Watchman prevents embolic stroke in non-valvular atrial fibrillation
• The Way Forward for Cost Effective Healthcare !!!!
• the way to go, the alternative fuil future is now
• There are reasons US Hospitals are slow to adopt e-records
• They're not selling toothpaste....
• Thiazides shown to be poor BP agents again, increasing diabetes risk.
• Third Generation Pneumococcal Vaccine
• This is it...
• This is partly or totally looked at a New Model for Healthcare in the US???
• Three Diagnostic Companies Comply with FDA
• Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone
• TNF blockers linked to cancer risk in children & teens
• To Get Health Care Reform: Take Two...They're Small(er)
• To Supplement or Not To Supplement... That is the Question?
• Too early to tell, let's see
• Top Line Is Not Enough
• Topiramate generics - anaother view
• Traby or AA for uncontrolled IOP
• Transdermal Patch with AGI-004 Reduces Chemo-Induced Diarrhea (CID)
• Treatment of Social Anxiety Disorderved
• U.S. Hospital Electronic Records Adoption Rate Even Worse than Thought
• UK Study Suggests that PAP and HPV Not Significantly Better Than Pap Alone
• Unclear how orlistat's mechanism can lead to liver damage. Likely a non-issue.
• Unmet challenges of movement to Electronic Medical Records
• Unusuall times call for Unusall annocements !!!
• Vaccinate Both Genders Against HPV
• Value Based Purchasing of Medicare Services Takes another Leap Forward
• Various Generic Topiramate Tablets Approved by FDA
• Victoza approval important milestone
• Walmart hardly seems best suited to offer physicians what they need to make EMRs work.
• Walmart strides into the digital medical record, but will it cure our national paperwork disease
• Wal-Mart to Try its Hand at Selling EMR Systems
• Wal-Mart's Plans to Enter EMR Market
• Watchman trial: right device, wrong patient population.
• we already have sumatriptan
• We must find a new way to target Alzheimer's Dementia
• Welcome addition to our armament, but overuse potential?
• What do you do to your best performer once the job is done
• What information do Physician Data Bases really provide?
• What True National Health Care Reform Must Accomplish
• What's in it for ME?
• What's the big deal about "winning" Victory Pharma?
• Where Did My Health Care Go?
• Who is the customer?
• Why Do so Few Hospitals have EMR
• Why Health Care Costs Keep Rising—And What to Do About It
• Why Physician-Owned Hospitals are Good
• Why should physician owned hospitals be banned?
• Will Microsoft (MSFT) refusal to be part of the secret kabal of "Cloud Manifesto" authors matter?
• Will the Adoption of Health Information Technology Really Improve Healthcare
• Will the Mass. plan for Global Payments influence the quality of M.D. care?
• Will The Medical Device Safety Act of 2009 Ultimately Benefit Patients?
• Will the new rapid test for C difficile be an important advance?
• Will the results of the new QVar Study affect How Physicians Use It to Treat Asthma?
• Will the results of the new QVar Study affect How Physicians Use It to Treat Asthma?
• Will the withdrawl of Efalizumab effect the biologic market?
• Will We Never Learn From Past Mistakes?
• Without Building the Health IT Superhighway Everything is a Pipedream
• Wockdardt needed cash Yesterday!!!
• Wockdardt Starts liquidating assests
• Wockhardt Slowly & steadly clearing its excess bagage